{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:41:50Z","timestamp":1765082510089,"version":"3.46.0"},"reference-count":17,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1988,12]]},"abstract":"<jats:p>The effectiveness of antacid maintenance therapy in preventing duodenal ulcer (DU) relapse was investigated. Two hundred and fifty one asymptomatic patients with healed DU were stratified into smokers and non-smokers and randomised to receive for one year either placebo, or Maalox TC three tablets (81 mmol) at bedtime (hs), or Maalox TC three tablets in the morning plus three tablets at bedtime (bd) (162 mmol), or cimetidine 400 mg at bedtime. A double dummy technique was used to render the study double blind. In 176 patients evaluable for efficacy, the cumulative relapse at one year was: placebo 57%; Maalox TC hs 39%; Maalox TC bd 23%; cimetidine 25%. Maalox TC bd and cimetidine were equally effective and superior to placebo (p less than 0.01) and bedtime Maalox TC (p less than 0.04). The benefit of treatment was significant for the overall sample and for the subgroup of smokers. The results for the non-smokers also supported efficacy for these two treatments but, perhaps because of small sample sizes, these comparisons were not significant. All 251 patients were assessed for safety. Approximately half the patients in each treatment group had adverse events, leading to withdrawal in three, seven, 12, and four patients on placebo, Maalox hs, Maalox bd, and cimetidine respectively. Diarrhoea occurred in 12 patients in Maalox TC bd and eight in each other group. Serum magnesium concentrations were unchanged; aluminium concentrations were higher than baseline at six and 12 months in both antacid groups and at 12 months in the cimetidine group but the differences were not significant. Maalox TC three tablets bd are as effective as cimetidine 400 mg at bedtime in reducing DU relapse and both are superior to placebo.<\/jats:p>","DOI":"10.1136\/gut.29.12.1748","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1748-1754","source":"Crossref","is-referenced-by-count":15,"title":["Antacid maintenance therapy in the prevention of duodenal ulcer relapse."],"prefix":"10.1136","volume":"29","author":[{"given":"K D","family":"Bardhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J O","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A B","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Y","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R I","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sontag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gaussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1988,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365528609015152","article-title":"Review. Antacids in the treatment of gastroduodenal ulcer","volume":"21","author":"Berstad, A.; Weberg, R.","year":"1986","unstructured":"Berstad A, Weberg R. Review. Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol 1986; 21: 385-91.","journal-title":"Scand J Gastroenterol"},{"key":"ref_2","first-page":"75","article-title":"Symposium on antacids","volume":"17","author":"Forssell, H.","year":"1982","unstructured":"Forssell H, Walan A, eds. Symposium on antacids. Scand J Gastroenterol [suppl] 1982; 17: 75.","journal-title":"Scand J Gastroenterol"},{"key":"ref_3","article-title":"Antacids in the eighties. Munchen-WienBaltimore: Urban and","author":"(ed, Halter F","year":"1982","unstructured":"Halter F (ed). Antacids in the eighties. Munchen-WienBaltimore: Urban and Schwarzenberg, 1982."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004836-198604000-00007","article-title":"Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer","volume":"8","author":"G, Bianchi Porro; F, Parente; M, Lazzaroni; E, Baroni S.Panza","year":"1986","unstructured":"Bianchi Porro G, Parente F, Lazzaroni M, Baroni S. Panza E. Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J Clin Gastroenterol 1986; 8: 141-5.","journal-title":"J Clin Gastroenterol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/00365528608996435","article-title":"Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence","volume":"21","author":"G, Bianchi Porro; M, Lazzaroni; F, Pace; M, Petrillo","year":"1986","unstructured":"Bianchi Porro G, Lazzaroni M, Pace F, Petrillo M. Long-term low-dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. Scand J Gastroenterol 1986; 21: 1144-6.","journal-title":"Scand J Gastroenterol"},{"key":"ref_6","article-title":"Statistical methods for survival analysis","author":"Lee, E.T.","year":"1980","unstructured":"Lee ET. Statistical methods for survival analysis. Belmont, California: Wadsworth, 1980."},{"key":"ref_7","article-title":"SAS user's guide: statistics","author":"SAS Institute, Inc","year":"1983","unstructured":"SAS Institute, Inc. SAS user's guide: statistics. Cary NC: SAS Institute Inc. 1983."},{"key":"ref_8","author":"Dixon, W.J.; Brown, M.B.; Engelman, L.","year":"1981","unstructured":"Dixon WJ, Brown MB, Engelman L, et al. BMDP Statistical software 1981. Berkley, California: University of California Press, 1981.","journal-title":"BMDP Statistical software"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1445-5994.1985.tb04065.x","article-title":"Choice of ulcer healing agent influences duodenal ulcer relapse rate and longterm clinical outcome","volume":"15","author":"AJ, McLean AJl Byrne; PM, Harrison; P, McCarthy; loannides-Demos L; FJ, Dudley","year":"1985","unstructured":"McLean AJl Byrne AJ, Harrison PM, McCarthy P, loannides-Demos L, Dudley FJ. Choice of ulcer healing agent influences duodenal ulcer relapse rate and longterm clinical outcome. Aust NZ J Med 1985; 15: 367-74.","journal-title":"Aust NZ J Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bmj.293.6555.1117","article-title":"Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?","volume":"293","author":"Miller, J.P.; Faragher, E.B.","year":"1986","unstructured":"Miller JP, Faragher EB. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment? Br MedJ 1986; 293: 1117-8.","journal-title":"Br MedJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198409133111101","article-title":"cigarette smoking and recurrence of duodenal ulcer","volume":"311","author":"Sontag, S.; Graham, D.Y.; Belsito, A.","year":"1984","unstructured":"Sontag S, Graham DY, Belsito A, et al. Cimetidine, cigarette smoking and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689-93.","journal-title":"N Engl J Med"},{"key":"ref_12","first-page":"380","volume-title":"Cimetidine in the treatment of duodenal ulcer. Gastroenterology [suppl]","volume":"74","author":"Binder, H.J.; Cocco, A.; Crossley, R.J.","year":"1978","unstructured":"Binder HJ, Cocco A, Crossley RJ, et al. Cimetidine in the treatment of duodenal ulcer. Gastroenterology [suppl] 1978; 74: 380-8."},{"key":"ref_13","first-page":"407","article-title":"Round table discussion on duodenal ulcer","volume":"\"[suppl]\" # \"74:\"","author":"McGuigan, J.E.","year":"1978","unstructured":"McGuigan JE. Round table discussion on duodenal ulcer. Gastroenterology [suppl] 1978; 74: 407-9.","journal-title":"Gastroenterology"},{"key":"ref_14","first-page":"31","article-title":"Cimetidine in duodenal ulceration","volume-title":"Cimetidine. The Westminster Hospital Symposium","author":"Bardhan, K.D.","year":"1978","unstructured":"Bardhan KD. Cimetidine in duodenal ulceration. In: Wastell C, Lance P, eds. Cimetidine. The Westminster Hospital Symposium. Edinburgh, London, New York: Churchill Livingstone, 1978: 31-56."},{"key":"ref_15","first-page":"112","article-title":"Effects of long-term antacid administration on mineral metabolism","volume-title":"Antacids in the eighties. Munchen-Wien-Baltimore: Urban and","author":"Lembcke, B.; Fuchs, C.; Hesch, R.D.; Caspary, W.F.","year":"1982","unstructured":"Lembcke B, Fuchs C, Hesch RD, Caspary WF. Effects of long-term antacid administration on mineral metabolism. In: Halter F, ed. Antacids in the eighties. Munchen-Wien-Baltimore: Urban and Schwarzenberg, 1982:112-22."},{"key":"ref_16","first-page":"123","article-title":"Evaluation of serum and urine electrolyte changes during therapy with a magnesiumaluminium containing antacid: results of a prospective study","volume-title":"Antacids in the eighties. Munchen-Wien-Baltimore: Urban and","author":"Halter, F.","year":"1982","unstructured":"Herzog P. Schmitt KF, Grendahl T, van der Linden Jr J, Holtermuller KH. Evaluation of serum and urine electrolyte changes during therapy with a magnesiumaluminium containing antacid: results of a prospective study. In: Halter F, ed. Antacids in the eighties. Munchen-Wien-Baltimore: Urban and Schwarzenberg, 1982: 123-40."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/00365528509089205","article-title":"Mineralmetabolic side-effects of low-dose antacids","volume":"20","author":"Weberg, R.; Berstad, A.; Aaseth, J.; Falch, J.A.","year":"1985","unstructured":"Weberg R, Berstad A, Aaseth J, Falch JA. Mineralmetabolic side-effects of low-dose antacids. Scand J Gastroenterol 1985; 20: 741-6.","journal-title":"Scand J Gastroenterol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.29.12.1748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:13:25Z","timestamp":1765077205000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.29.12.1748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1988,12,1]]},"published-print":{"date-parts":[[1988,12]]}},"alternative-id":["10.1136\/gut.29.12.1748"],"URL":"https:\/\/doi.org\/10.1136\/gut.29.12.1748","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}